Edition |
Second edition. |
Description |
1 online resource (xv, 431 pages). |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
|
text file html rda |
Bibliography |
Includes bibliographical references and index. |
Note |
Print version record. |
Summary |
Praise for the First Edition: "As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information by the time the book is [published] it is outdated." [Tumor Board Review] is fresh and just out of the oven I haven't seen any book in oncology like this so far I think my investment in this book was wise and worth it."--Humaid Al- Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists--both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 350 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam. The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of relevant staging; and several "tumor board style" illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process. New to the Second Edition of Tumor Board Review: Revised and updated with state-of-the-art knowledge Presents the most recent guidelines and management. -- Rittenhouse. |
Contents |
Cover; Title; Copyright; Contents; Contributors; Preface to the Second Edition; Preface to the First Edition; Share Tumor Board Review: Guideline and Case Reviews in Oncology, Second Edition; Chapter 1: Head and Neck Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Overview of Staging; Site-Specific Staging for SCCHN; Case Summaries; Locoregionally Advanced Disease; Evidence-Based Case Discussion; Recurrent/Metastatic SCCHN; Evidence-Based Case Discussion; Summary; Review Questions; References; Chapter 2: Thyroid Cancer. |
|
Epidemiology, Risk Factors, Natural History, and PathologyDifferentiated Thyroid Carcinoma; Staging; Case Summaries; Early-Stage Papillary Thyroid Cancer: Stage I; Evidence-Based Case Discussion; Differentiated Follicular Thyroid Cancer: Late-Stage Follicular Thyroid Cancer; Evidence-Based Case Discussion; Medullary Thyroid Cancer; Evidence-Based Case Discussion; Anaplastic Thyroid Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 3: Non-Small-Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Early-Stage NSCLC. |
|
Evidence-Based Case DiscussionSurgery and Adjuvant Chemotherapy in Early-Stage NSCLC; Regional (Stage III) NSCLC; Evidence-Based Case Discussion; Metastatic NSCLC, Case 1; Evidence-Based Case Discussion; Metastatic NSCLC, Case 2; Evidence-Based Case Discussion; Recurrent NSCLC; Evidence-Based Case Discussion; Review Questions; References; Chapter 4: Small Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; LS-SCLC: Combined Modality Therapy; Evidence-Based Case Discussion; ES-SCLC: Systemic Palliative Therapy; Evidence-Based Case Discussion. |
|
Review QuestionsReferences; Chapter 5: Breast Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Ductal Carcinoma In Situ; Early-Stage ER+ Breast Cancer; Early-Stage ER+ Breast Cancer, Stage I or II; Early-Stage TNBC; Locally Advanced HER2+ Breast Cancer; Metastatic Breast Cancer; A Special Note on Breast Cancer in Pregnancy; Review Questions; References; Chapter 6: Esophageal Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Locally Advanced Resectable Esophageal Cancer; Evidence-Based Case Discussion. |
|
Locally Advanced Unresectable Esophageal CancerEvidence-Based Case Discussion; Metastatic Esophageal Cancer; Evidence-Based Case Discussion; Acknowledgment; Review Questions; References; Chapter 7: Gastric Cancer; Epidemiology, Natural History, Risk Factors, and Pathology; Staging; Case Summaries; Resectable Gastric Cancer; Evidence-Based Case Discussion; Locally Advanced Unresectable and Metastatic Gastric Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 8: Pancreatic Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries. |
Subject |
Tumors -- Case studies.
|
|
Evidence-based medicine -- Case studies.
|
|
Evidence-based medicine.
|
|
Evidence-Based Medicine |
|
Neoplasms |
|
Evidence-Based Practice |
|
Tumeurs -- Études de cas.
|
|
Médecine factuelle -- Études de cas.
|
|
Médecine factuelle.
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Evidence-based medicine
|
|
Tumors
|
Genre/Form |
Case Reports |
|
Practice Guideline |
|
Case studies
|
|
Case studies.
|
|
Études de cas.
|
Added Author |
Todd, Robert F., III, editor.
|
|
Cooney, Kathleen A., editor.
|
|
Hayes, Teresa G., editor.
|
|
Mims, Martha Pritchett, editor.
|
|
Worden, Francis P., editor.
|
Other Form: |
Print version: Tumor board review. Second edition 9781620700600 (DLC) 2014040453 (OCoLC)893099401 |
ISBN |
9781617052231 (electronic bk.) |
|
161705223X (electronic bk.) |
|
9781620700600 |
|
1620700603 |
Standard No. |
AU@ 000062420397 |
|
DEBBG BV042794979 |
|
DEBBG BV044073562 |
|
DEBSZ 493159142 |
|
AU@ 000066757546 |
|
AU@ 000069303060 |
|